企業プロフィール
Ligand Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- LGND
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
291.77 USD (-0.96%)
終値
最終更新: 2026年8月17日
4.66B USD
時価総額
株価変動の要因
As of Aug 17, 2026, LGND closed down 0.96% at $291.77. No new same-company headline was identified in the current news window.
企業概要
事業概要
Ligand Pharmaceuticals is a royalty and technology-enabled biopharma company that monetizes its platform through partnered programs, royalties, and biopharma investments.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Ligand sits in specialty biopharma and royalty-driven healthcare.
ビジネスモデルの特徴
The business relies on royalties, milestones, and platform economics rather than a single large commercial franchise.
バイオ業界での位置付け
Ligand is a unique biotech finance-and-royalty hybrid whose stock often tracks deal flow and royalty visibility.
今後のカタリスト
- Ligand's catalysts are royalty income, portfolio monetization, and capital-allocation updates that show how the company keeps converting assets into cash flow. The story is more about financial engineering than a single drug event.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。